tick-borne encephalitis vaccine
Trade name: TICOVAC
Vaccineapproved
Approved
Aug 13, 2021
Tick-borne encephalitis vaccine is a vaccine used to prevent tick-borne encephalitis (TBE). The disease is most common in Central and Eastern Europe, and Northern Asia. More than 87% of people who receive the vaccine develop immunity. It is not useful following the bite of an infected tick. It is given by injection into a muscle. — Wikipedia
Clinical trial activity
34 trials · 27 clinical orgs · 1 marketing orgs
Phase 1
0
Phase 2
14
Phase 3
9
Phase 4
17
Earliest trial started Apr 1, 1998 (NCT00161746)
Timeline
Indications
Approved for
Studied for
- Allergy and Immunology · Phase 4
- Arthritis, Rheumatoid · Phase 2
- Encephalitis, Tick-Borne · Phase 4
- Flavivirus Infections · Phase 2
- Immune System Diseases · Phase 4
- Immunosuppression Therapy · Phase 2
- Influenza, Human · Phase 3
- Tick-Borne Diseases · Phase 4
- Tuberculosis · Phase 2
- Vaccine Efficacy · Phase 4
- Vaccines · Phase 4
- Virus Diseases · Phase 4
Mechanism of action
- Tick-borne encephalitis virusImmunity, active
Tick-borne encephalitis virus immunity, active
Approval history
- approvedAug 13, 2021
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaTick-borne encephalitis vaccine ↗
Also known as
- fsme-immun
- fsme immun cc
- tbe vaccine
- tick-borne encephalitis vaccine
- tick-borne encephalitis virus
- ticovac
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04573205 | Phase 4 | Jan 31, 2021 | Orebro University |
| NCT04648241 | Phase 3 | Jan 18, 2021 | Pfizer |
| NCT03294135 | Phase 4 | Oct 5, 2017 | GlaxoSmithKline |
| NCT04017052 | Phase 4 | Apr 15, 2015 | Medical University of Vienna |
| NCT02318069 | Phase 2/Phase 3 (Phase 3) | Jan 1, 2015 | Helsingfors university, Karolinska Institute, Sormland County Council, Sweden |
| NCT01991067 | Phase 2 | Jul 1, 2014 | Austrian Science Fund (FWF), University of Vienna |
| NCT02511535 | Phase 4 | Sep 1, 2013 | University of Vienna |
| NCT02511587 | Phase 4 | Oct 1, 2012 | Medical University of Vienna, University of Vienna |
| NCT01710189 | Phase 4 | Oct 1, 2012 | University of London |
| NCT01582698 | Phase 4 | Apr 1, 2012 | Baxalta |
| NCT01361776 | Phase 2/Phase 3 (Phase 3) | Sep 1, 2011 | Karolinska Institute, Sormland County Council, Sweden |
| NCT01131910 | Phase 2 | May 1, 2010 | Karolinska Institute, Sormland County Council, Sweden |
| NCT01031537 | Phase 2 | Sep 25, 2009 | National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) |
| NCT00894686 | Phase 4 | Apr 1, 2009 | Baxalta, Pfizer |
| NCT00840801 | Phase 3 | Feb 1, 2009 | Baxalta, Pfizer |
| NCT00804219 | Phase 4 | Dec 1, 2008 | Medical University of Vienna, University of Vienna |
| NCT00644059 | Phase 3 | Nov 1, 2007 | Novartis |
| NCT00503529 | Phase 4 | Jul 1, 2007 | John Paul II Hospital, Krakow, Pfizer |
| NCT00461695 | Phase 4 | May 1, 2007 | University of Zurich |
| NCT00890422 | Phase 2 | Mar 1, 2007 | ASOKLIF, Baxalta, KH Elisabethinen Linz |
Showing 20 of 34 trials
Page 1 / 2
Organizations
Research & Development (27)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pfizer | For profit | 15 | 15 | 3 | 1998 |
| Baxalta | For profit | 10 | 1 | 3 | 1998 |
| Novartis | For profit | 4 | 4 | 2 | 2005 |
| University of Vienna | Academic/Hospital | 4 | 4 | 2 | 2008 |
| Karolinska Institute | Academic/Hospital | 3 | 0 | 2 | 2010 |
| Medical University of Vienna | Academic/Hospital | 3 | 1 | 1 | 2008 |
| Sormland County Council, Sweden | Government | 3 | 3 | 2 | 2010 |
| Szpital Jana Pawla II Oddzial Neuoinfekcji | Academic/Hospital | 3 | 0 | 2 | 2001 |
| Atopia Diagnostyka i Leczenie Chorob Alergicznych i Ukladu Oddechowego | Academic/Hospital | 2 | 0 | 1 | 2001 |
| Pantamed sp. z o o. | Academic/Hospital | 2 | 0 | 1 | 2001 |
| Przedsiebiorstwo Uslug Medycznych Centrum Medyczne Nowa Huta | Academic/Hospital | 2 | 0 | 1 | 2001 |
| Samodzielny Publiczny Szpital | Academic/Hospital | 2 | 0 | 1 | 2001 |
| Wojewodzki Szpital | Academic/Hospital | 2 | 0 | 1 | 2001 |
| Zespol Opieki Zdrowotnej w Debicy | Academic/Hospital | 2 | 0 | 1 | 2001 |
| ASOKLIF | Academic/Hospital | 1 | 0 | 1 | 2007 |
| Austrian Science Fund (FWF) | Government | 1 | 0 | 1 | 2014 |
| Chiron | For profit | 1 | 0 | 1 | 2006 |
| GlaxoSmithKline | For profit | 1 | 1 | 1 | 2017 |
| Helsingfors university | Academic/Hospital | 1 | 0 | 1 | 2015 |
| John Paul II Hospital, Krakow | Academic/Hospital | 1 | 0 | 1 | 2007 |
27 organizations
Page 1 / 2